DE GIORGI, UGO FEDERICO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.619
AS - Asia 1.083
EU - Europa 488
SA - Sud America 191
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 28
OC - Oceania 2
Totale 3.480
Nazione #
US - Stati Uniti d'America 1.575
SG - Singapore 427
CN - Cina 231
VN - Vietnam 156
BR - Brasile 143
IT - Italia 121
PL - Polonia 111
HK - Hong Kong 71
DE - Germania 57
BD - Bangladesh 46
GB - Regno Unito 45
FR - Francia 30
CA - Canada 28
RU - Federazione Russa 26
UA - Ucraina 26
ID - Indonesia 25
JP - Giappone 25
TR - Turchia 23
AR - Argentina 22
FI - Finlandia 21
IN - India 17
SE - Svezia 14
MX - Messico 12
ZA - Sudafrica 10
EC - Ecuador 9
ES - Italia 8
IQ - Iraq 8
NL - Olanda 8
PK - Pakistan 8
VE - Venezuela 7
AT - Austria 6
IR - Iran 5
KG - Kirghizistan 5
UZ - Uzbekistan 5
MA - Marocco 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
JO - Giordania 3
LT - Lituania 3
MY - Malesia 3
SA - Arabia Saudita 3
AL - Albania 2
AZ - Azerbaigian 2
BE - Belgio 2
BO - Bolivia 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
KW - Kuwait 2
TH - Thailandia 2
TN - Tunisia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AO - Angola 1
AU - Australia 1
CD - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TW - Taiwan 1
Totale 3.414
Città #
Singapore 233
Ashburn 198
Fairfield 142
San Jose 141
Warsaw 110
Santa Clara 100
Woodbridge 84
Chandler 76
Houston 72
Beijing 71
Hong Kong 69
Council Bluffs 54
Ho Chi Minh City 48
Cambridge 46
Seattle 45
Wilmington 39
Hanoi 35
Los Angeles 35
Dallas 30
Milan 30
New York 29
Jacksonville 26
Tokyo 25
Dearborn 23
Princeton 23
Dong Ket 20
Lauterbourg 20
Jakarta 19
São Paulo 19
Ann Arbor 18
Izmir 17
Helsinki 15
Munich 14
San Diego 12
Chicago 11
London 11
Shanghai 11
Toronto 11
Ferrara 10
Orem 10
Buffalo 9
Atlanta 8
Mexico City 8
Nanjing 8
Haiphong 7
Moscow 6
Nanchang 6
Stockholm 6
Baghdad 5
Bishkek 5
Biên Hòa 5
Boardman 5
Brooklyn 5
Frankfurt am Main 5
Hebei 5
Johannesburg 5
San Francisco 5
The Dalles 5
Tianjin 5
Turku 5
Bologna 4
Bremen 4
Chennai 4
Denver 4
Montreal 4
Phoenix 4
Quito 4
Rio de Janeiro 4
Tashkent 4
Addison 3
Bắc Giang 3
Cape Town 3
Caracas 3
Columbus 3
Da Nang 3
Dhaka 3
Jiaxing 3
Modugno 3
Mumbai 3
New Westminster 3
Ninh Bình 3
Nuremberg 3
Poplar 3
Shenyang 3
São Gonçalo 3
Thái Nguyên 3
Vienna 3
Abu Dhabi 2
Addis Ababa 2
Amman 2
Amsterdam 2
Ankara 2
Baku 2
Belo Horizonte 2
Boston 2
Brasília 2
Brussels 2
Cairo 2
Calderara di Reno 2
Campina Grande do Sul 2
Totale 2.236
Nome #
18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide 282
68 Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients 260
Early use of abiraterone and radium-223 in metastatic prostate cancer 246
PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis 223
[177 Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet? 199
68Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer 187
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer 176
Testicular Microlithiasis and Testicular Germ Cell Tumours: a seven year retrospective study 168
Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide 154
Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review 154
Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients 153
CAR-T cell therapy: A potential new strategy against prostate cancer 151
Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide [Eur J Nucl Med Mol Imaging, DOI 10.1007/s00259-015-3042-5] 145
Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell transplantation for high-risk breast cancer: results from the italian National Registry 140
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 140
Spotlight on PSMA as a new theranostic biomarker for bladder cancer 132
Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers 124
Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial 118
Targeted radioactive therapy for prostate cancer 112
Combining liquid biopsy and functional imaging analysis in metastatic castration-resistant prostate cancer helps predict treatment outcome 111
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration-resistant cancer patients 105
Totale 3.480
Categoria #
all - tutte 19.480
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.480


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022156 0 8 4 3 4 12 18 35 8 14 15 35
2022/2023187 22 5 23 6 26 30 18 11 21 1 17 7
2023/202473 15 5 5 3 7 3 1 5 0 1 3 25
2024/2025631 13 23 55 18 69 89 21 25 113 96 73 36
2025/20261.536 142 75 120 157 271 79 182 105 134 145 79 47
2026/202797 26 71 0 0 0 0 0 0 0 0 0 0
Totale 3.480